片仔癀(600436.SH)漲5%創歷史新高 主導產品片仔癀錠劑價格上調
格隆匯1月21日丨片仔癀(600436.SH)半日收漲5.01%報132.3元,盤中創出歷史新高價133.48元,成交8.67億元,最新總市值798億元。該股2019年漲27.46%,2020年迄今為止漲20.42%。片仔癀昨晚公告,公司主導產品片仔癀錠劑國內市場零售價格將從530元/粒上調到590元/粒,供應價格相應上調約40元/粒;海外市場供應價格相應上調約5.80美元/粒。另外,1月17日,公司發公告稱2019年度預計實現淨利13.74億元,同比增長20.24%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.